Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Two River is a venture capital organization founded to build life science companies by partnering with scientific founders and experienced management teams. Established in New York, the firm focuses on leveraging its capital to invest in companies with strong intellectual property and proven leadership. The organization has a significant presence in the life sciences sector, particularly in oncology, immunotherapy, and synthetic and chemical biology.
Currently, Two River manages a portfolio of nine companies, demonstrating its commitment to advancing healthcare through innovative technologies. The firm operates from its office located at 689 Fifth Avenue, 12th Floor, New York, NY 10022. Two River's approach combines financial investment with operational support, corporate development, and leadership recruitment, ensuring that its portfolio companies have the resources necessary to succeed.
Over the years, Two River has established itself as a key player in the life sciences investment space, focusing on groundbreaking science that can transform patient outcomes. The firm’s notable milestones include partnerships with leading companies in the biotech sector, contributing to advancements in therapies for critical health challenges.
Two River's investment strategy centers on the life sciences sector, specifically targeting groundbreaking scientific advancements that have the potential to transform patient outcomes. The firm invests at various stages, including seed, Series A, and Series B, primarily within North America. The check sizes typically align with the needs of early-stage life science companies, allowing for significant capital infusion to support development.
The organization emphasizes its commitment to supporting scientific founders by providing not only capital but also operational capabilities, corporate development, transaction support, and leadership recruitment. This comprehensive support structure is designed to help founders advance their research from bench to bedside, ensuring that innovative therapies reach the market effectively.
Two River's focus areas include oncology, immunotherapy, and synthetic biology, reflecting its dedication to investing in sectors that address critical health challenges. The firm seeks to partner with companies that possess strong intellectual property and proven leadership, aligning with its mission to drive meaningful advancements in healthcare.
Two River's portfolio includes nine notable companies, each contributing to advancements in the life sciences sector:
This diverse portfolio highlights Two River's commitment to investing in companies that are at the forefront of scientific innovation, particularly in areas that can significantly impact patient care and treatment outcomes.
Arie Belldegrun, MD - Chairman & Partner. Dr. Belldegrun has extensive experience in the life sciences sector, having co-founded several successful biotech companies.
Joshua Kazam - Partner. Kazam brings a wealth of experience in venture capital and has been involved in numerous successful investments in the life sciences.
David Tanen - Partner. Tanen has a strong background in finance and has led investments in various biotech companies.
Chris Wilfong - Operating Partner. Wilfong focuses on operational support for portfolio companies, leveraging his experience in the life sciences.
Nicole van de Leuv - Principal. Van de Leuv plays a key role in sourcing and evaluating investment opportunities within the life sciences sector.
David Chang, MD, PhD - Venture Partner. Dr. Chang has a strong background in clinical research and drug development.
Sean Algeo - Chief Financial Officer. Algeo oversees the financial operations of Two River, ensuring sound financial management.
Owen Witte, MD - Advisor. Dr. Witte provides strategic guidance based on his extensive experience in cancer research.
James S. Economou, MD, PhD - Advisor. Dr. Economou offers insights into clinical development and regulatory affairs.
To pitch to Two River, founders should use the contact form available on their website. The pitch deck should include an overview of the technology, market analysis, team qualifications, and financial projections. Response times may vary, but founders can expect to hear back within a few weeks.
Warm introductions are preferred, as they can facilitate a more favorable review process. Founders are encouraged to connect with Two River through industry events or mutual contacts to increase their chances of securing a meeting.
In recent months, Two River has continued to expand its portfolio, focusing on innovative life sciences companies. Notable investments include partnerships with companies developing therapies for blood cancers and autoimmune diseases.
The firm has also been active in supporting its existing portfolio companies, providing operational capabilities and leadership recruitment to enhance their growth potential. Two River's commitment to advancing healthcare through scientific innovation remains a central theme in its recent activities.
What are Two River's investment criteria?
Two River focuses on investing in life sciences companies that demonstrate groundbreaking science with the potential to transform patient outcomes. The firm seeks companies with strong intellectual property and proven leadership.
How can I apply or pitch to Two River?
Founders interested in pitching to Two River should prepare a detailed presentation that outlines their technology, market potential, and team qualifications. Direct outreach through their website is recommended.
What makes Two River different from other venture capital firms?
Two River differentiates itself by providing not only capital but also operational support, corporate development, and leadership recruitment to its portfolio companies, ensuring they have the resources needed to succeed.
What is the geographic scope of Two River's investments?
The firm primarily invests in North America, focusing on life sciences companies that are positioned to make significant advancements in healthcare.
What is the typical check size for investments?
While specific check sizes are not disclosed, Two River invests at various stages, including seed, Series A, and Series B, aligning with the capital needs of early-stage life science companies.
What kind of post-investment involvement does Two River have?
Two River actively supports its portfolio companies through operational capabilities, corporate development, and leadership recruitment, ensuring that they have the necessary resources to advance their research and business objectives.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.